TIPS术后肝性脑病危险因素的研究进展
Research Progress on Risk Factors of Hepatic Encephalopathy after TIPS
DOI: 10.12677/ACM.2023.13102218, PDF,   
作者: 何倩倩, 李 坤*：山东第一医科大学第一附属医院(山东省千佛山医院)消化内科，山东 济南
关键词: 经颈静脉肝内门体分流术；肝性脑病；危险因素；Transjugular Intrahepatic Portosystemic Shunt； Hepatic Encephalopathy； Risk Factors
摘要: 经颈静脉肝内门体分流术(transjugular intrahepatic portosystemic shunt, TIPS)是一种能够有效缓解门静脉高压的介入治疗技术，被广泛用于治疗食管胃底静脉出血、顽固性腹水、Budd-Chiari综合征等。(Hepatic encephalopathy, HE)是TIPS术后最为典型的分流相关疾病，TIPS术后肝性脑病(HE)的发生延长了患者的住院天数并降低了患者的生活质量，所以TIPS术后预防肝性脑病是一项很重要的临床任务。术前评估患者发生肝性脑病的风险因素，以及找出TIPS术后发生HE的高风险人群，通过积极预防，密切随访，对尽可能实现减少HE的发病率具有重要意义。本文旨在通过对相关文献进行复习来增强临床医生对该病的认识，为临床医生对肝性脑病的诊断、治疗及预防提供依据。
Abstract: Transjugular intrahepatic portosystemic shunt (TIPS) is an interventional therapy technique that can effectively relieve portal hypertension. It is widely used in the treatment of esophageal fundus venous hemorrhage, refractory ascites, Budd-Chiari syndrome, and so on. Hepatic encephalopathy (HE) is the most typical shingal-related disease after TIPS. The occurrence of hepatic encephalopa-thy (HE) after TIPS prolongs the length of stay and reduces the quality of life of patients. Therefore, the prevention of hepatic encephalopathy after TIPS is a very important clinical task. Preoperative assessment of the risk factors of patients with hepatic encephalopathy and identification of high-risk groups of HE patients after TIPS are of great significance for reducing the incidence of HE as much as possible through active prevention and close follow-up. The purpose of this paper is to enhance the understanding of the disease by reviewing the relevant literature, and to provide the basis for the diagnosis, treatment and prevention of hepatic encephalopathy.
文章引用：何倩倩, 李坤. TIPS术后肝性脑病危险因素的研究进展[J]. 临床医学进展, 2023, 13(10): 15870-15876. https://doi.org/10.12677/ACM.2023.13102218

参考文献

[1] 中华医学会肝病学分会. 肝硬化肝性脑病诊疗指南[J]. 中华内科杂志, 2018, 57(10): 705-718. [Google Scholar] [CrossRef] [PubMed]
[2] Lee, H.L. and Lee, S.W. (2022) The Role of Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Advantages and Pitfalls. Clinical and Molecular Hepatology, 28, 121-134. [Google Scholar] [CrossRef] [PubMed]
[3] Patel, R.K., Chandel, K., Tripathy, T.P. and Mukund, A. (2021) Com-plications of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Era of the Stent Graft—What the Intervention-ists Need to Know? European Journal of Radiology, 144, Article ID: 109986. [Google Scholar] [CrossRef] [PubMed]
[4] Zuo, L., Lv, Y., Wang, Q., et al. (2019) Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Porto-systemic Shunt Creation. Journal of Vascular and Interventional Radiology, 30, 148-153.e2. [Google Scholar] [CrossRef] [PubMed]
[5] Vilstrup, H., Amodio, P., Bajaj, J., et al. (2014) Hepatic Encephalo-pathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology, 60, 715-735. [Google Scholar] [CrossRef] [PubMed]
[6] Weissenborn, K. (2019) Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles. Drugs, 79, 5-9. [Google Scholar] [CrossRef] [PubMed]
[7] Wijdicks, E.F. (2016) Hepatic Encephalopathy. The New England Journal of Medicine, 375, 1660-1670. [Google Scholar] [CrossRef] 
[8] Zeng, X., Yin, C., Sun, C.Y., et al. (2023) Prevalence and Risk Factors of Covert Hepatic Encephalopathy in Cirrhotic Patients: A Multicenter Study in China. Journal of Digestive Dis-eases, 24, 122-132. [Google Scholar] [CrossRef] [PubMed]
[9] Mamone, G., Milazzo, M., Di Piazza, A., et al. (2022) Transjugular Intrahepatic Portosystemic Shunt (TIPS) Complications: What Diagnostic Radiologists Should Know. Abdominal Radi-ology (NY), 47, 4254-4270. [Google Scholar] [CrossRef] [PubMed]
[10] Coronado, W.M., Ju, C., Bullen, J. and Kapoor, B. (2020) Pre-dictors of Occurrence and Risk of Hepatic Encephalopathy after TIPS Creation: A 15-Year Experience. CardioVascular and Interventional Radiology, 43, 1156-1164. [Google Scholar] [CrossRef] [PubMed]
[11] Lu, K. (2023) Cellular Pathogenesis of Hepatic Encephalopathy: An Update. Biomolecules, 13, Article No. 396. [Google Scholar] [CrossRef] [PubMed]
[12] 孟书静, 张强, 苏醒, 等. 肝硬化患者发生肝性脑病危险因素的Meta分析[J]. 承德医学院学报, 2022, 39(4): 302-307.
[13] Merola, J., Chaudhary, N., Qian, M., et al. (2014) Hy-ponatremia: A Risk Factor for Early Overt Encephalopathy after Transjugular Intra-Hepatic Portosystemic Shunt Crea-tion. Journal of Clinical Medicine, 3, 359-372. [Google Scholar] [CrossRef] [PubMed]
[14] Younas, A., Riaz, J., Chughtai, T., et al. (2021) Hyponatremia and Its Correlation with Hepatic Encephalopathy and Severity of Liver Disease. Cureus, 13, e13175. [Google Scholar] [CrossRef] [PubMed]
[15] Guimarães, L., Piedade, J., Duarte, J., et al. (2023) Hepatic Encephalo-pathy in Cirrhotic Patients with Bacterial Infections: Frequency, Clinical Characteristics, and Prognostic Relevance. Journal of Clinical and Experimental Hepatology, 13, 559-567. [Google Scholar] [CrossRef] [PubMed]
[16] Bai, Z., Guo, X., Tacke, F., Li, Y., Li, H. and Qi, X. (2019) Asso-ciation of Serum Albumin Level with Incidence and Mortality of Overt Hepatic Encephalopathy in Cirrhosis during Hos-pitalization. Therapeutic Advances in Gastroenterology, 12, 1-14. [Google Scholar] [CrossRef] [PubMed]
[17] 陈丽娜, 潘陈为, 刘敏欧, 等. 肝硬化患者肝性脑病风险评估量表模型构建与预测价值研究[J]. 中国现代医生, 2023, 61(18): 29-32+73.
[18] 唐艳芳, 刘旭东, 王文鑫, 等. 肝硬化合并轻微型肝性脑病的临床特点以及相关影响因素分析[J]. 传染病信息, 2022, 35(4): 316-320.
[19] 申权, 郑晖, 杨维竹, 等. TIPS术后门脉显影和肝脏体积对肝功能及并发肝性脑病的影响[J]. 中华介入放射学电子杂志, 2020, 8(1): 15-18.
[20] Liu, J., Zhou, C., Wang, Y., et al. (2021) The Combination of Child-Pugh Score and Quantitative CT-Based Spleen Volume Could Predict the Risk of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation. Abdominal Radiology (NY), 46, 3464-3470. [Google Scholar] [CrossRef] [PubMed]
[21] Ruf, A., Dirchwolf, M. and Freeman, R.B. (2022) From Child-Pugh to MELD Score and Beyond: Taking a Walk down Memory Lane. Annals of Hepatology, 27, Article ID: 100535. [Google Scholar] [CrossRef] [PubMed]
[22] 熊峰. 不同肝功能评分模型对TIPS术后显性肝性脑病的预测价值[D]: [硕士学位论文]. 昆明: 昆明医科大学, 2022.
[23] Krishnan, A., Woreta, T.A., Vaidya, D., et al. (2023) MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement. Journal of Clinical and Translational Hepatology, 11, 38-44.
[24] Nardelli, S., et al. (2019) Muscle Alterations Are Associated with Minimal and Overt Hepatic Encephalopathy in Patients with Liver Cir-rhosis. Hepatology, 70, 1704-1713. [Google Scholar] [CrossRef] [PubMed]
[25] Bhanji, R.A., Moctezuma-Velazquez, C., Duarte-Rojo, A., et al. (2018) Myosteatosis and Sarcopenia Are Associated with Hepatic Encephalopathy in Patients with Cirrhosis. Hepatology International, 12, 377-386. [Google Scholar] [CrossRef] [PubMed]
[26] Yang, C., Zhu, X., Liu, J., et al. (2022) Development and Valida-tion of Prognostic Models to Estimate the Risk of Overt Hepatic Encephalopathy after TIPS Creation: A Multicenter Study. Clinical and Translational Gastroenterology, 13, e00461. [Google Scholar] [CrossRef] [PubMed]
[27] Dasarathy, S. and Merli, M. (2016) Sarcopenia from Mecha-nism to Diagnosis and Treatment in Liver Disease. Journal of Hepatology, 65, 1232-1244. [Google Scholar] [CrossRef] [PubMed]
[28] Bhatia Kapoor, P., Benjamin, J., Tripathi, H., et al. (2023) Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury. Turkish Journal of Gastroenterology, 34, 406-412. [Google Scholar] [CrossRef] [PubMed]
[29] Wijarnpreecha, K., Werlang, M., Panjawatanan, P., et al. (2020) Asso-ciation between Sarcopenia and Hepatic Encephalopathy: A Systematic Review and Meta-Analysis. Annals of Hepatolo-gy, 19, 245-250. [Google Scholar] [CrossRef] [PubMed]
[30] Ma, Y.J., Cao, Z.X., Li, Y. and Feng, S.Y. (2019) Proton Pump Inhibitor Use Increases Hepatic Encephalopathy Risk: A Systematic Review and Meta-Analysis. World Journal of Gas-troenterology, 25, 2675-2682. [Google Scholar] [CrossRef] [PubMed]
[31] Dai, R., Sag, A.A., Martin, J.G., et al. (2021) Proton Pump Inhibitor Use Is Associated with Increased Rates of Post-TIPS Hepatic Encephalopathy: Replication in an Independent Patient Cohort. Clinical Imaging, 77, 187-192. [Google Scholar] [CrossRef] [PubMed]
[32] Gairing, S.J., Schleicher, E.M. and Labenz, C. (2023) Diabetes Mellitus-Risk Factor and Potential Future Target for Hepatic Encephalopathy in Patients with Liver Cirrhosis? Metabolic Brain Disease, 38, 1691-1700. [Google Scholar] [CrossRef] [PubMed]
[33] Labenz, C., Nagel, M., Kremer, W.M., et al. (2020) Association between Diabetes Mellitus and Hepatic Encephalopathy in Patients with Cirrhosis. Alimentary Pharmacology & Thera-peutics, 52, 527-536. [Google Scholar] [CrossRef] [PubMed]
[34] Li, X., Partovi, S., Coronado, W.M., et al. (2022) Hepatic Encephalopathy after TIPS Placement: Predictive Factors, Prevention Strategies, and Management. CardioVascular and Interventional Radiology, 45, 570-577. [Google Scholar] [CrossRef] [PubMed]
[35] Lewis, D.S., Lee, T.-H., Konanur, M., et al. (2019) Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugu-lar Intrahepatic Portosystemic Shunt Creation. Journal of Vascular and Interventional Radiology, 30, 163-169. [Google Scholar] [CrossRef] [PubMed]
[36] 张浩, 潘佳佳, 蒋晓芬, 等. 门静脉压力梯度预测TIPS后高危人群肝性脑病的研究[J]. 中华肝脏病杂志, 2021, 29(1): 72-74.
[37] Miraglia, R., Maruzzelli, L., Di Piazza, A., et al. (2019) Transjugular Intrahepatic Portosystemic Shunt Using the New Gore Viatorr Controlled Expansion Endoprosthe-sis: Prospective, Single-Center Preliminary Experience. CardioVascular and Interventional Radiology, 42, 78-86. [Google Scholar] [CrossRef] [PubMed]
[38] Srinivasa, R.N., Srinivasa, R.N., Chick, J., Hage, A. and Saad, W.A. (2018) Transjugular Intrahepatic Portosystemic Shunt Reduction Using the Gore Viatorr Controlled Expansion Endoprosthesis: Hemo-Dynamics of Reducing an Established 10-mm TIPS to 8-mm Indiameter. CardioVascular and Interventional Radiology, 41, 518-521. [Google Scholar] [CrossRef] [PubMed]
[39] Yao, X., He, S., Wei, M. and Qin, J.P. (2022) Influence of Dif-ferent Portal Vein Branches on Hepatic Encephalopathy during Intrahepatic Portal Shunt via Jugular Vein. World Journal of Gastroenterology, 28, 4467-4470. [Google Scholar] [CrossRef] [PubMed]
[40] Ma, J., Luo, J., Zhang, W., et al. (2023) The Influence of Shunting Left/Right Portal Vein Branch on Post-TIPS Hepatic Encephalopathy: A Study Protocol for Multicenter Randomized Blinded Controlled Trial. Trials, 24, Article No. 312. [Google Scholar] [CrossRef] [PubMed]
[41] Luo, S.H., Chu, J.G., Huang, H., Zhao, G.R. and Yao, K.C. (2019) Targeted Puncture of Left Branch of Intrahepatic Portal Vein in Transjugular Intrahepatic Portosystemic Shunt to Reduce Hepatic Encephalopathy. World Journal of Gastroenterology, 25, 1088-1099. [Google Scholar] [CrossRef] [PubMed]
[42] Zuo, K., Wang, C., Wang, J., Xia, F.F. and Song, T. (2021) Transjugular Intrahepatic Portosystemic Shunt through Left Branch versus Right Branch of Portal Vein: A Me-ta-Analysis. Abdominal Radiology (NY), 46, 1718-1725. [Google Scholar] [CrossRef] [PubMed]
[43] Yang, C., Chen, Y., Wang, C., et al. (2022) Portal Flow Diver-sion Based on Portography Is Superior than Puncture Site in the Prediction of Overt Hepatic Encephalopathy after TIPS Creation. BMC Gastroenterology, 22, Article No. 363. [Google Scholar] [CrossRef] [PubMed]
[44] Trebicka, J., Bastgen, D., Byrtus, J., Praktiknjo, M., Terstiegen, S., Meyer, C., et al. (2019) Smaller-Diameter Covered Transjugu-lar Intrahepatic Porto-Systemic Shunt Stents Are Associated with Increased Survival. Clinical Gastroenterology and Hepatology, 17, 2793-2799.e1. [Google Scholar] [CrossRef] [PubMed]
[45] Liu, J., Ma, J., Zhou, C., et al. (2021) Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Cre-ation. Clinical and Translational Gastroenterology, 12, e00376. [Google Scholar] [CrossRef] [PubMed]
[46] Li, W., Duan, Y., Liu, Z., et al. (2022) Clinical Value of Hemodynamic Changes in Diagnosis of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt. Scandinavian Journal of Gastroenterology, 1-6. [Google Scholar] [CrossRef] [PubMed]
[47] Wang, J.F., Ma, J.Q., Luo, J.J., et al. (2020) Hemodynamic Response in Cirrhotic Patients with Transjugular Intrahepatic Portosystemic Shunt. Chinese Journal of Internal Medicine, 59, 700-705.
[48] 陈兵勇, 陈婕, 李景珊, 等. 二维斑点追踪成像评价肝硬化失代偿期患者心室功能的价值[J]. 岭南心血管病杂志, 2021, 27(1): 85-90.

为你推荐